Featured Research

from universities, journals, and other organizations

Hamstring grafts prove more effective in ACL knee reconstruction, study says

Date:
February 19, 2011
Source:
American Orthopaedic Society for Sports Medicine
Summary:
Patients receiving anterior cruciate ligament knee reconstruction with a hamstring tendon graft rather than a knee tendon graft were less likely to suffer from pain and mobility issues 15 years after surgery, say researchers.

Patients receiving anterior cruciate ligament (ACL) knee reconstruction with a hamstring tendon graft rather than a knee tendon graft were less likely to suffer from pain and mobility issues 15 years after surgery, say researchers presenting a study at the American Orthopaedic Society for Sports Medicine's Specialty Day in San Diego, California (Feb. 19).

"While we have seen excellent results in terms of knee symptoms and function with both graft types, comparing the two definitely showed differences, "said Leo Pinczewski, MD, lead researcher and surgeon with the North Sydney Orthopaedic and Sports Medicine Center in Wollstonecraft, Australia. "Patients with a hamstring graft reported less knee pain and discomfort and demonstrated a higher activity level."

Surgeons performing ACL graft surgery aim to eliminate instability and quickly return patients to pre-injury function levels. Since ACL ruptures are relatively common, especially in young athletes, surgical procedures are routinely performed.

This study adds to Pinczewski's most recent work exploring the overall success rate of ACL knee reconstruction in athletes after 15 years. "We know that these surgeries work, but this information helps us determine which approaches can be most effective. Getting athletes back on the field is certainly important, but long term success rates are crucial as well," said Pinczewski.

The study followed 180 knee reconstruction patients, with 90 (48 men and 42 women between the ages of 15-42 years) receiving a patellar tendon (PT) graft and the other 90 (47 men and 43 women between the ages of 13-52 years) receiving a hamstring tendon (HT) graft. After 15 years, 80 percent of the PT group and 73 percent of the HT group were assessed based on their symptoms of pain, swelling and knee mobility.

The HT group demonstrated significantly higher activity levels, with 77 percent performing at least strenuous activities, compared to 62 percent being able to perform strenuous activity in the PT group. In evaluating pain when kneeling, 42 percent of the PT group patients reported moderate or greater pain, while 26 percent of the HT group reported pain. The PT group also showed worse outcomes in tests for motion loss and osteoarthritis.

Reasons for increased osteoarthritis in the hamstring tendon graft were uncertain and recommended for further investigation.


Story Source:

The above story is based on materials provided by American Orthopaedic Society for Sports Medicine. Note: Materials may be edited for content and length.


Cite This Page:

American Orthopaedic Society for Sports Medicine. "Hamstring grafts prove more effective in ACL knee reconstruction, study says." ScienceDaily. ScienceDaily, 19 February 2011. <www.sciencedaily.com/releases/2011/02/110219160019.htm>.
American Orthopaedic Society for Sports Medicine. (2011, February 19). Hamstring grafts prove more effective in ACL knee reconstruction, study says. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2011/02/110219160019.htm
American Orthopaedic Society for Sports Medicine. "Hamstring grafts prove more effective in ACL knee reconstruction, study says." ScienceDaily. www.sciencedaily.com/releases/2011/02/110219160019.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com
Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins